341 related articles for article (PubMed ID: 18086530)
1. Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production.
Xiong H; Callaghan D; Jones A; Walker DG; Lue LF; Beach TG; Sue LI; Woulfe J; Xu H; Stanimirovic DB; Zhang W
Neurobiol Dis; 2008 Mar; 29(3):422-37. PubMed ID: 18086530
[TBL] [Abstract][Full Text] [Related]
2. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
[TBL] [Abstract][Full Text] [Related]
3. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics.
Roberds SL; Anderson J; Basi G; Bienkowski MJ; Branstetter DG; Chen KS; Freedman SB; Frigon NL; Games D; Hu K; Johnson-Wood K; Kappenman KE; Kawabe TT; Kola I; Kuehn R; Lee M; Liu W; Motter R; Nichols NF; Power M; Robertson DW; Schenk D; Schoor M; Shopp GM; Shuck ME; Sinha S; Svensson KA; Tatsuno G; Tintrup H; Wijsman J; Wright S; McConlogue L
Hum Mol Genet; 2001 Jun; 10(12):1317-24. PubMed ID: 11406613
[TBL] [Abstract][Full Text] [Related]
4. A GPCR/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis.
Teng L; Zhao J; Wang F; Ma L; Pei G
Cell Res; 2010 Feb; 20(2):138-53. PubMed ID: 20066010
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
6. The adipocyte differentiation protein APMAP is an endogenous suppressor of Aβ production in the brain.
Mosser S; Alattia JR; Dimitrov M; Matz A; Pascual J; Schneider BL; Fraering PC
Hum Mol Genet; 2015 Jan; 24(2):371-82. PubMed ID: 25180020
[TBL] [Abstract][Full Text] [Related]
7. ABCG1 and ABCG4 Suppress γ-Secretase Activity and Amyloid β Production.
Sano O; Tsujita M; Shimizu Y; Kato R; Kobayashi A; Kioka N; Remaley AT; Michikawa M; Ueda K; Matsuo M
PLoS One; 2016; 11(5):e0155400. PubMed ID: 27196068
[TBL] [Abstract][Full Text] [Related]
8. Enhanced amyloid-β generation by γ-secretase complex in DRM microdomains with reduced cholesterol levels.
Hata S; Hu A; Piao Y; Nakaya T; Taru H; Morishima-Kawashima M; Murayama S; Nishimura M; Suzuki T
Hum Mol Genet; 2020 Feb; 29(3):382-393. PubMed ID: 31841137
[TBL] [Abstract][Full Text] [Related]
9. Identification of new Presenilin-1 phosphosites: implication for γ-secretase activity and Aβ production.
Matz A; Halamoda-Kenzaoui B; Hamelin R; Mosser S; Alattia JR; Dimitrov M; Moniatte M; Fraering PC
J Neurochem; 2015 May; 133(3):409-21. PubMed ID: 25458374
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
11. Plasmalogens inhibit APP processing by directly affecting γ-secretase activity in Alzheimer's disease.
Rothhaar TL; Grösgen S; Haupenthal VJ; Burg VK; Hundsdörfer B; Mett J; Riemenschneider M; Grimm HS; Hartmann T; Grimm MO
ScientificWorldJournal; 2012; 2012():141240. PubMed ID: 22547976
[TBL] [Abstract][Full Text] [Related]
12. γ-Secretase, apolipoprotein E and cellular cholesterol metabolism.
Walter J
Curr Alzheimer Res; 2012 Feb; 9(2):189-99. PubMed ID: 21605030
[TBL] [Abstract][Full Text] [Related]
13. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.
Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF
Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433
[TBL] [Abstract][Full Text] [Related]
14. Genetic Variation in δ-Opioid Receptor Associates with Increased β- and γ-Secretase Activity in the Late Stages of Alzheimer's Disease.
Sarajärvi T; Marttinen M; Natunen T; Kauppinen T; Mäkinen P; Helisalmi S; Laitinen M; Rauramaa T; Leinonen V; Petäjä-Repo U; Soininen H; Haapasalo A; Hiltunen M
J Alzheimers Dis; 2015; 48(2):507-16. PubMed ID: 26402014
[TBL] [Abstract][Full Text] [Related]
15. Amyloid precursor protein compartmentalization restricts beta-amyloid production: therapeutic targets based on BACE compartmentalization.
Gandhi S; Refolo LM; Sambamurti K
J Mol Neurosci; 2004; 24(1):137-43. PubMed ID: 15314262
[TBL] [Abstract][Full Text] [Related]
16. Exercise and BDNF reduce Aβ production by enhancing α-secretase processing of APP.
Nigam SM; Xu S; Kritikou JS; Marosi K; Brodin L; Mattson MP
J Neurochem; 2017 Jul; 142(2):286-296. PubMed ID: 28382744
[TBL] [Abstract][Full Text] [Related]
17. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
Ohno M; Hiraoka Y; Lichtenthaler SF; Nishi K; Saijo S; Matsuoka T; Tomimoto H; Araki W; Takahashi R; Kita T; Kimura T; Nishi E
Neurobiol Aging; 2014 Jan; 35(1):213-22. PubMed ID: 23954170
[TBL] [Abstract][Full Text] [Related]
18. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
[TBL] [Abstract][Full Text] [Related]
19. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
[TBL] [Abstract][Full Text] [Related]
20. Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles.
Hook VY; Toneff T; Aaron W; Yasothornsrikul S; Bundey R; Reisine T
J Neurochem; 2002 Apr; 81(2):237-56. PubMed ID: 12064471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]